Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Dermatology

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 147 articles: HTML format Text format

Single Articles

March 2010
1. MURPHY NC , Biankin AV, Millar EK, McNeil CM, et al
   Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status.
   Int J Cancer. 2010;126:1445-53.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. MASSET A , Maillard C, Sounni N, Jacobs N, et al
   Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. CLAERHOUT S , Verschooten L, Van Kelst S, De Vos R, et al
   Concomitant inhibition of AKT and autophagy is required for efficient cisplatin-induced apoptosis of metastatic skin carcinoma.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. RICHMOND-SINCLAIR NM , Pandeya N, Williams GM, Neale R, et al
   Clinical signs of photodamage are associated with basal cell carcinoma multiplicity and site: A 16-year longitudinal study.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
5. BARILLARI G , Franzese O, Iovane A, Ensoli B, et al
   Spindle cells from Acquired Immune Deficiency Syndrome (AIDS)-associated Kaposi's sarcoma (KS) lesions express telomerase activity directly relating to the RNA levels of fibroblast growth factor (FGF)-2.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles   
   
   
   
6. OLSEN CM , Carroll HJ, Whiteman DC
   Estimating the attributable fraction for melanoma: A meta-analysis of pigmentary characteristics and freckling.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. SHAO W , Growney JD, Feng Y, O'Connor G, et al
   Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: Defining molecular mechanisms of resistance.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
8. KHOLMANSKIKH O , van Baren N, Brasseur F, Ottaviani S, et al
   Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte-differentiation antigens.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
9. YU KS , Lee Y, Lim CM, Park EC, et al
   The protease inhibitor, elafin, induces p53-dependent apoptosis in human melanoma cells.
   Int J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. GUILLAUME P , Baumgaertner P, Neff L, Rufer N, et al
    Novel soluble HLA-A2/MELAN-A complexes selectively stain a differentiation defective subpopulation of CD8+ T cells in melanoma patients.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
11. DZIAMAN T , Huzarski T, Gackowski D, Rozalski R, et al
    Elevated level of 8-oxo-7,8-dihydro-2'-deoxyguanosine in leukocytes of BRCA1 mutation carriers compared to healthy controls.
    Int J Cancer. 2009;125:2209-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
12. DE MILITO A , Canese R, Marino ML, Borghi M, et al
    pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. PLASMEIJER EI , Neale RE, Buettner PG, de Koning MN, et al
    Betapapillomavirus infection profiles in tissue sets from cutaneous squamous cell-carcinoma patients.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. JOHANSSON CC , Mougiakakos D, Trocme E, All-Ericsson C, et al
    Expression and prognostic significance of iNOS in uveal melanoma.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. FURLANETTO TW
    Vitamin D2 could be one of the protective phytochemicals.
    Int J Cancer. 2009;125:1994.
    PubMed     Text format     Related articles   
    
    
    
16. SATZGER I , Mattern A, Kuettler U, Weinspach D, et al
    MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. OCHSENREITHER S , Fusi A, Busse A, Letsch A, et al
    Long term presence of a single predominant tyrosinase-specific T-cell clone associated with disease control in a patient with metastatic melanoma.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. DEN OUDSTEN BL , Van Heck GL, Van der Steeg AF, Roukema JA, et al
    Second operation is not related to psychological outcome in breast cancer patients.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. LANOY E , Costagliola D, Engels EA
    Skin cancers associated with HIV infection and solid organ transplant among elderly adults.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. LOPEZ-FAUQUED M , Gil R, Grueso J, Hernandez J, et al
    The dual PI3K/mTOR inhibitor (PI-103) promotes immunosupression, in vivo tumor growth and increases survival of sorafenib treated melanoma cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. YANG ZQ , Liu G, Bollig-Fischer A, Haddad R, et al
    Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers.
    Int J Cancer. 2009;125:1613-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. RIEBER M , Strasberg Rieber M
    DN-R175H p53 mutation is more effective than p53 interference in inducing epithelial disorganization and activation of proliferation signals in human carcinoma cells: role of E-cadherin.
    Int J Cancer. 2009;125:1604-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
23. SCATOLINI M , Grand MM, Grosso E, Venesio T, et al
    Altered molecular pathways in melanocytic lesions.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. PATSOS G , Germann A, Gebert J, Dihlmann S, et al
    Restoration of Absent in Melanoma 2 (AIM2) induces G2/M cell cycle arrest and promotes invasion of colorectal cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. TOLSTOV YL , Pastrana DV, Feng H, Becker JC, et al
    Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays.
    Int J Cancer. 2009;125:1250-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. SHUDA M , Arora R, Kwun HJ, Feng H, et al
    Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors.
    Int J Cancer. 2009;125:1243-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. FUJIMOTO H , Sangai T, Ishii G, Ikehara A, et al
    Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression.
    Int J Cancer. 2009;125:1276-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. KUSTERS-VANDEVELDE HV , Van Leeuwen A, Verdijk MA, de Koning MN, et al
    CDKN2A but not TP53 mutations nor HPV presence predict poor outcome in metastatic squamous cell carcinoma of the skin.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. MIYATA T , Yonekura K, Utsunomiya A, Kanekura T, et al
    Cutaneous type adult T-cell leukemia/lymphoma is a characteristic subtype and includes erythema/papule and nodule/tumor subgroups.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. ELAZAR V , Adwan H, Bauerle T, Rohekar K, et al
    Sustained delivery and efficacy of polymeric nanoparticles containing osteopontin and bone sialoprotein antisenses in rats with breast cancer bone metastasis.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. ZHOU Y , Chen H, Ma XL, Xie HJ, et al
    Fusion protein of adenovirus E4orf4 and human epidermal growth factor inhibits tumor cell growth.
    Int J Cancer. 2009;125:1186-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
32. ALESKANDARANY MA , Green AR, Rakha EA, Mohammed RA, et al
    Growth fraction as a predictor of response to chemotherapy in node negative breast cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. NADERI A , Liu J, Bennett IC
    BEX2 regulates mitochondrial apoptosis and G1 cell cycle in breast cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. IKEBUCHI K , Chano T, Ochi Y, Tameno H, et al
    RB1CC1 activates the promoter and expression of RB1 in human cancer.
    Int J Cancer. 2009;125:861-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. SAHNI A , Arevalo MT, Sahni SK, Simpson-Haidaris PJ, et al
    The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells.
    Int J Cancer. 2009;125:577-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. FILLMORE RA , Mitra A, Xi Y, Ju J, et al
    Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth.
    Int J Cancer. 2009;125:556-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. DUNNEBIER T , Bermejo JL, Haas S, Fischer HP, et al
    Common variants in the UBC9 gene encoding the SUMO-conjugating enzyme are associated with breast tumor grade.
    Int J Cancer. 2009;125:596-602.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
38. ANEJA R , Asress S, Dhiman N, Awasthi A, et al
    Non-toxic melanoma therapy by a novel tubulin-binding agent.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. AITKEN JF , Elwood M, Baade PD, Youl P, et al
    Clinical whole-body skin examination reduces the incidence of thick melanomas.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. DESFRANCOIS J , Derre L, Corvaisier M, Le Mevel B, et al
    Increased frequency of nonconventional double positive CD4CD8 alphabeta T cells in human breast pleural effusions.
    Int J Cancer. 2009;125:374-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. OY GF , Slipicevic A, Davidson B, Faye RS, et al
    Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. SINGH S , Sadanandam A, Varney ML, Nannuru KC, et al
    Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
43. BIGIONI M , Parlani M, Bressan A, Bellarosa D, et al
    Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. KIM SH , Miller FR, Tait L, Zheng J, et al
    Proteomic and phosphoproteomic alterations in benign, premalignant and tumor human breast epithelial cells and xenograft lesions: biomarkers of progression.
    Int J Cancer. 2009;124:2813-28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. CHEN C , Zhou Z, Sheehan CE, Slodkowska E, et al
    Overexpression of WWP1 is associated with the estrogen receptor and insulin-like growth factor receptor 1 in breast carcinoma.
    Int J Cancer. 2009;124:2829-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. YANG XR , Pfeiffer RM, Wheeler W, Yeager M, et al
    Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. EDMONDS MD , Hurst DR, Vaidya KS, Stafford LJ, et al
    Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. KUO YC , Su CH, Liu CY, Chen TH, et al
    Transforming growth factor-beta induces CD44 cleavage that promotes migration of MDA-MB-435s cells through the up-regulation of membrane type 1-matrix metalloproteinase.
    Int J Cancer. 2009;124:2568-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
49. KEET AW , Al-Rafae M, Chappuis PO, Brunet JS, et al
    Long-term outcome after neo-adjuvant chemotherapy for breast cancer in BRCA1/2 carriers.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles   
    
    
    
50. VOSSELER S , Lederle W, Airola K, Obermueller E, et al
    Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. FUKAZAWA T , Maeda Y, Matsuoka J, Tanaka N, et al
    Drug-regulatable cancer cell death induced by BID under control of the tissue-specific, lung cancer-targeted TTS promoter system.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. ZHANG C , Liu Y, Gao Y, Shen J, et al
    Modified heparins inhibit integrin alpha(IIb)beta(3) mediated adhesion of melanoma cells to platelets in vitro and in vivo.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. CHARPIN C , Secq V, Giusiano S, Carpentier S, et al
    A signature predictive of disease outcome in breast carcinomas, identified by quantitative immunocytochemical assays.
    Int J Cancer. 2009;124:2124-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. JUSTENHOVEN C , Pierl CB, Haas S, Fischer HP, et al
    Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors.
    Int J Cancer. 2009;124:2077-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. NJOR SH , Pedersen AT, Schwartz W, Hallas J, et al
    Minimizing misclassification of hormone users at mammography screening.
    Int J Cancer. 2009;124:2159-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. SOHN KJ , Jang H, Campan M, Weisenberger DJ, et al
    The methylenetetrahydrofolate reductase C677T mutation induces cell-specific changes in genomic DNA methylation and uracil misincorporation: a possible molecular basis for the site-specific cancer risk modification.
    Int J Cancer. 2009;124:1999-2005.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
57. SCHERER D , Nagore E, Bermejo JL, Figl A, et al
    Melanocortin receptor 1 variants and melanoma risk: A study of 2 European populations.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. ZHANG Y , Su H, Rahimi M, Tochihara R, et al
    EGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. VAN DEN EYNDEN GG , Van Laere SJ, Van der Auwera I, Trinh XB, et al
    Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles   
    
    
    
60. YOUL PH , Janda M, Kimlin M
    Vitamin D and sun protection: the impact of mixed public health messages in Australia.
    Int J Cancer. 2009;124:1963-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. KARMAKAR S , Foster EA, Smith CL
    Estradiol downregulation of the tumor suppressor gene BTG2 requires estrogen receptor-alpha and the REA corepressor.
    Int J Cancer. 2009;124:1841-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. SCHMIDT J , Bosserhoff AK
    Processing of MIA protein during melanoma cell migration.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. CASABONNE D , Lally A, Mitchell L, Michael KM, et al
    A case-control study of cutaneous squamous cell carcinoma among Caucasian organ transplant recipients: The role of antibodies against human papillomavirus and other risk factors.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. DE KONING PJ , Bovenschen N, Leusink FK, Broekhuizen R, et al
    Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. KAWASE T , Matsuo K, Suzuki T, Hiraki A, et al
    FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: Results of a case control study in Japan.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. KWITNIEWSKI M , Jankowski D, Jaskiewicz K, Dziadziuszko H, et al
    Photodynamic therapy with 5-aminolevulinic acid and diamino acid derivatives of protoporphyrin IX reduces papillomas in mice without eliminating transformation into squamous cell carcinoma of the skin.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. MCSHERRY EA , McGee SF, Jirstrom K, Doyle EM, et al
    JAM-A expression positively correlates with poor prognosis in breast cancer patients.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. GOLUBOVSKAYA VM , Conway-Dorsey K, Edmiston SN, Tse CK, et al
    FAK overexpression and p53 mutations are highly correlated in human breast cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. BUTT S , Borgquist S, Anagnostaki L, Landberg G, et al
    Parity and age at first childbirth in relation to the risk of different breast cancer subgroups.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. O'MALLEY S , Su H, Zhang T, Ng C, et al
    TOB suppresses breast cancer tumorigenesis.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. IBIEBELE TI , van der Pols JC, Hughes MC, Marks GC, et al
    Dietary fat intake and risk of skin cancer: A prospective study in Australian adults.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. KOTSOPOULOS J , Tworoger SS, Devivo I, Hankinson SE, et al
    +331G/A variant in the progesterone receptor gene, postmenopausal hormone use and risk of breast cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. LI L , Dragulev B, Zigrino P, Mauch C, et al
    The invasive potential of human melanoma cell lines correlates with their ability to alter fibroblast gene expression in vitro and the stromal microenvironment in vivo.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. DEY S , Boffetta P, Mathews A, Brennan P, et al
    Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. MASALA G , Assedi M, Ambrogetti D, Sera F, et al
    Physical activity and mammographic breast density in a Mediterranean population: the EPIC Florence longitudinal study.
    Int J Cancer. 2009;124:1654-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
76. FELICETTI F , Parolini I, Bottero L, Fecchi K, et al
    Caveolin-1 tumor-promoting role in human melanoma.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. GAJALAKSHMI V , Mathew A, Brennan P, Rajan B, et al
    Breastfeeding and breast cancer risk in India: A multicenter case-control study.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. SANGRAJRANG S , Sato Y, Sakamoto H, Ohnami S, et al
    Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. MCCOLGAN P , Sharma P
    Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. BOGAN C , Chen J, O'Sullivan MG, Cormier RT, et al
    Loss of EphA2 receptor tyrosine kinase reduces ApcMin/+ tumorigenesis.
    Int J Cancer. 2009;124:1366-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. DE SOUZA VR , Cabrera WK, Galvan A, Ribeiro OG, et al
    Aryl hydrocarbon receptor polymorphism modulates DMBA-induced inflammation and carcinogenesis in phenotypically selected mice.
    Int J Cancer. 2009;124:1478-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. BERTUCCI F , Finetti P, Cervera N, Charafe-Jauffret E, et al
    How different are luminal A and basal breast cancers?
    Int J Cancer. 2009;124:1338-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. DE STEFANI E , Deneo-Pellegrini H, Boffetta P, Ronco AL, et al
    Dietary patterns and risk of cancer: a factor analysis in Uruguay.
    Int J Cancer. 2009;124:1391-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. SRINIVASAN S , Koduru S, Kumar R, Venguswamy G, et al
    Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. BONNET-DUQUENNOY M , Papon J, Mishellany F, Labarre P, et al
    Targeted radionuclide therapy of melanoma: Anti-tumoural efficacy studies of a new (131)I labelled potential agent.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. YE L , Gho WM, Chan FL, Chen S, et al
    Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overexpressing aromatase.
    Int J Cancer. 2009;124:1028-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
87. PETERSON NB , Beeghly-Fadiel A, Gao YT, Long J, et al
    Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. FUJITA T , Liu W, Doihara H, Wan Y, et al
    An in vivo study of Cdh1/APC in breast cancer formation.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. MOORE AB , Shannon J, Chen C, Lampe JW, et al
    Dietary and stored iron as predictors of breast cancer risk: A nested case-control study in Shanghai.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. JANG JH , Cotterchio M, Gallinger S, Knight JA, et al
    Family history of hormonal cancers and colorectal cancer risk: A case-control study conducted in Ontario.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. JAYASEKARA H , Karahalios E, Thursfield V, Giles GG, et al
    Season of diagnosis has no effect on survival from malignant melanoma.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. TERRASI M , Fiorio E, Mercanti A, Koda M, et al
    Functional analysis of the -2548G/A leptin gene polymorphism in breast cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. HYDER SM , Liang Y, Wu J
    Estrogen regulation of thrombospondin-1 in human breast cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. ZHANG CX , Ho SC, Chen YM, Fu JH, et al
    Greater vegetable and fruit intake is associated with a lower risk of breast cancer among Chinese women.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. WRIGHT TG , Singh VK, Li JJ, Foley JH, et al
    Increased production and secretion of HGF alpha-chain and an antagonistic HGF fragment in a human breast cancer progression model.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. VARNA M , Lehmann-Che J, Turpin E, Marangoni E, et al
    p53 dependent cell-cycle arrest triggered by chemotherapy in xenografted breast tumors.
    Int J Cancer. 2009;124:991-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. QI C , Zhu YT, Hu L, Zhu YJ, et al
    Identification of Fat4 as a candidate tumor suppressor gene in breast cancers.
    Int J Cancer. 2009;124:793-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. NUCCITELLI R , Chen X, Pakhomov AG, Baldwin WH, et al
    A new pulsed electric field therapy for melanoma disrupts the tumor's blood supply and causes complete remission without recurrence.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. JAMES VJ
    Fiber diffraction of skin and nails provides an accurate diagnosis of malignancies.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. RISBERG K , Fodstad O, Andersson Y
     The melanoma specific 9.2.27PE immunotoxin efficiently kills melanoma cells in vitro.
     Int J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. NAN H , Kraft P, Hunter DJ, Han J, et al
     Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians.
     Int J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. KASSEM A , Technau K, Kurz AK, Pantulu D, et al
     Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients.
     Int J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. MIGNONE LI , Giovannucci E, Newcomb PA, Titus-Ernstoff L, et al
     Dietary carotenoids and the risk of invasive breast cancer.
     Int J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. LARSSON SC , Bergkvist L, Wolk A
     Glycemic load, glycemic index and breast cancer risk in a prospective cohort of Swedish women.
     Int J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. HOLLOSI P , Yakushiji JK, Fong KS, Csiszar K, et al
     Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells.
     Int J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
106. CHEN YT , Hsu M, Lee P, Shin SJ, et al
     Cancer/testis antigen CT45: Analysis of mRNA and protein expression in human cancer.
     Int J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. KULASINGAM V , Zheng Y, Soosaipillai A, Leon AE, et al
     Activated leukocyte cell adhesion molecule: A novel biomarker for breast cancer.
     Int J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. LIPWORTH L , Tarone RE, Friis S, Ye W, et al
     Cancer among Scandinavian women with cosmetic breast implants: a pooled long-term follow-up study.
     Int J Cancer. 2009;124:490-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. KAMANGAR F , Diaw L, Wei WQ, Abnet CC, et al
     Serum pepsinogens and risk of esophageal squamous dysplasia.
     Int J Cancer. 2009;124:456-60.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. NDONG JD , Jean D, Rousselet N, Frade R, et al
     Down-regulation of the expression of RB18A/MED1, a cofactor of transcription, triggers strong tumorigenic phenotype of human melanoma cells.
     Int J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. FEDERICI C , Brambilla D, Lozupone F, Matarrese P, et al
     Pleiotropic function of ezrin in human metastatic melanomas.
     Int J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
112. ERFURT C , Muller E, Emmerling S, Klotz C, et al
     Melanoma-associated chondroitin sulphate proteoglycan as a new target antigen for CD4(+) T cells in melanoma patients.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. WOODS LM , Rachet B, O'Connell D, Lawrence G, et al
     Large differences in patterns of breast cancer survival between Australia and England: A comparative study using cancer registry data.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. GAUDET MM , Hunter K, Pharoah P, Dunning AM, et al
     Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. ADELAIDE J , Finetti P, Charafe-Jauffret E, Wicinski J, et al
     Absence of ESR1 amplification in a series of breast cancers.
     Int J Cancer. 2008;123:2970-2.
     PubMed     Text format     Related articles   
     
     
     
116. GIOTOPOULOS G , Armstrong C, Osman A, Peat I, et al
     Refining the evidence for GSTA1 and eNOS genetic effects on risk of radiotherapy-induced telangiectasia.
     Int J Cancer. 2008;123:2973-4.
     PubMed     Text format     Related articles   
     
     
     
117. KRICKER A , Newman B, Gertig DM, Goumas C, et al
     Why do large breast cancers still present in a population offered screening?
     Int J Cancer. 2008;123:2907-14.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. KABAT GC , Cross AJ, Park Y, Schatzkin A, et al
     Meat intake and meat preparation in relation to risk of postmenopausal breast cancer in the NIH-AARP diet and health study.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. VASILJEVIC N , Andersson K, Bjelkenkrantz K, Kjellstrom C, et al
     The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
120. BARCLAY JL , Anderson ST, Waters MJ, Curlewis JD, et al
     SOCS3 as a tumor suppressor in breast cancer cells, and its regulation by PRL.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. LANIGAN F , McKiernan E, Brennan DJ, Hegarty S, et al
     Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. FRIEDENREICH CM , Gregory J, Kopciuk KA, Mackey JR, et al
     Prospective cohort study of lifetime physical activity and breast cancer survival.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. GERADTS J
     KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer (Int J Cancer 123: 2239-2246, 2008).
     Int J Cancer. 2008.
     PubMed     Text format     Related articles   
     
     
     
124. DOREN M , Greiser EM
     Re: Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles   
     
     
     
125. APPLEYARD MV , O'Neill MA, Murray KE, Paulin FE, et al
     Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. MOLLOY AP , Martin FT, Dwyer RM, Griffin TP, et al
     Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. ERIN N , Wang N, Xin P, Bui V, et al
     Altered gene expression in breast cancer liver metastases.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. ROD NH , Hansen AM, Nielsen J, Schnohr P, et al
     Low-risk factor profile, estrogen levels, and breast cancer risk among postmenopausal women.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. WANG B , Mi M, Wang J, Wei N, et al
     Does the increase of endogenous steroid hormone levels also affect breast cancer risk in Chinese women? A case-control study in Chongqing, China.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
130. SADR-NABAVI A , Ramser J, Volkmann J, Naehrig J, et al
     Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. SHEN J , Gammon MD, Terry MB, Wang Q, et al
     Telomere length, oxidative damage, antioxidants and breast cancer risk.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. UHM JE , Park YH, Yi SY, Cho EY, et al
     Treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer patients who received platinum-containing chemotherapy.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. SWEENEY KJ , Boran S, Fitzpatrick P, Merrigan AB, et al
     Postmenopausal hormone therapy and prevalent round screening mammography.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles   
     
     
     
134. WAN J , Sazani P, Kole R
     Modification of HER2 pre-mRNA alternative splicing and its effects on breast cancer cells.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. HENNIS AJ , Hambleton IR, Wu SY, Leske MC, et al
     Breast cancer incidence and mortality in a Caribbean population: Comparisons with African-Americans.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. BRAITHWAITE D , Tammemagi CM, Moore DH, Ozanne EM, et al
     Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. ZHANG M , Huang J, Xie X, Holman CD, et al
     Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2008
138. COUTO E , Banks E, Reeves G, Pirie K, et al
     Family history and breast cancer tumour characteristics in screened women.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. HABERMANN JK , Doering J, Hautaniemi S, Roblick UJ, et al
     The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. SHEN J , Ambrosone CB, Zhao H
     Novel genetic variants in microRNA genes and familial breast cancer.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. BORGQUIST S , Jirstrom K, Anagnostaki L, Manjer J, et al
     Anthropometric factors in relation to different tumor biological subgroups of postmenopausal breast cancer.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. LAGIOU P , Georgila C, Samoli E, Lagiou A, et al
     Estrogen alpha and progesterone receptor expression in the normal mammary epithelium in relation to breast cancer risk.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. CONROTTO P , Roesli C, Rybak J, Kischel P, et al
     Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. BREMER TM , Jacquemier J, Charafe-Jauffret E, Viens P, et al
     Prognostic marker profile to assess risk in stage I-III hormone receptor-positive breast cancer patients.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. MCGRATH M , Lee IM, Buring J, Hunter DJ, et al
     Novel breast cancer risk alleles and endometrial cancer risk.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. THIEBAUT AC , Chajes V, Gerber M, Boutron-Ruault MC, et al
     Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. TINARI N , Lattanzio R, Querzoli P, Natoli C, et al
     High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: